Gut microbiota dysregulation plays a key role in the pathogenesis of nonalcoholic fatty liver
disease (NAFLD) through its metabolites. Therefore, the restoration of the gut microbiota and …

Gut microbiota is a microecosystem composed of various microorganisms. It plays an
important role in human metabolism, and its metabolites affect different tissues and organs …

Non-alcoholic fatty liver disease (NAFLD) is reaching epidemic proportions, with a global
prevalence of 25% in the adult population. Non-alcoholic steatohepatitis (NASH), which can …

Chronic liver disease encompasses diseases that have various causes, such as alcoholic
liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Gut microbiota …

Nonalcoholic steatohepatitis (NASH) is one of the most common chronic liver diseases in
the world, yet no pharmacotherapies are available. The lack of translational animal models …

Aflatoxin B1 (AFB1) is a widespread mycotoxin in food and feed. Although the liver is the
main target organ of AFB1, the intestine is the first exposure organ to AFB1. However, the …

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease
in children and adolescents. Although obesity is the leading cause of NAFLD, the etiologies …

Bile acids (BAs) are amphipathic molecules synthetized in the liver. They are primarily
involved in the digestion of nutrients. Apart from their role in dietary lipid absorption, BAs …

Nonalcoholic steatohepatitis (NASH) is a serious disease threatening public health, and its
pathogenesis remains largely unclear. Recent scientific research has shown that intestinal …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common
chronic liver disease worldwide. Its occurrence and progression involve the process from …